OCRA is excited to see the work fueled by our new AI Accelerator Grant resonating with a broad array of audiences. Since the Global Ovarian Cancer Research Consortium announced the inaugural AI Accelerator Grant on February 19, coverage has appeared across health, science, and business media outlets.
The $1 million global research award—with an additional $1 million in compute support from Microsoft’s AI for Good Lab—will support an international team of researchers using AI to predict survival and treatment response in high-grade serous ovarian cancer, the most common and deadly form of the disease.
The research team will analyze one of the largest and most comprehensive international collections of ovarian cancer data assembled to date, integrating tumor samples, clinical records, immune features, genetic information, and lifestyle factors from thousands of patients across international research groups.
